Position in TWST
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$69,958
+$41,080 QoQ
Shares Held
680
+16.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#266
of 334 holders
Holding Since
Sep 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TWST Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Pacer Advisors, Inc. holds $369,664,886 across 21 Diagnostics & Research names. TWST ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
668,811 | $129,227,661 | |
| 2 | LH |
Labcorp Holdings Inc.
|
300,846 | $84,236,880 | |
| 3 | DGX |
Quest Diagnostics Inc
|
381,995 | $80,963,840 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
33,719 | $17,751,030 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
31,102 | $16,471,308 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
29,281 | $14,680,322 | |
| 7 | DHR |
Danaher Corp /De/
|
50,016 | $9,527,047 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
13,557 | $3,074,592 |
All Filings in TWST
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69,958 | 680 | Shares | Sole | 2026-08-13 | |
| 2024-06-30 | $28,878 | 586 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $39,044 | 1,138 | Shares | Sole | 2024-05-10 | |
| 2021-03-31 | $67,627 | 546 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $131,117 | 928 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $147,381 | 1,940 | Shares | Sole | 2020-10-19 | |
| No filing history on record for this holder in this stock. | ||||||